Your Skin Makes This. It Makes Less of It Every Year.
Summary.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a tripeptide found naturally in human plasma, saliva, and urine. It functions as a biological repair signal: when present in tissue, it activates genes involved in collagen and elastin synthesis, reduces inflammatory gene expression, and initiates wound healing processes in dermal fibroblasts. Plasma concentrations are highest in young adults and decline by more than half by the sixth decade of life — a pattern that correlates with measurable reductions in skin repair speed and collagen output.
Peer-reviewed research published in the International Journal of Molecular Sciences (2018) and BioMed Research International (2015) documents GHK-Cu's ability to modulate gene expression across thousands of pathways relevant to skin regeneration. The limiting factor for topical use is delivery: GHK-Cu cannot cross the stratum corneum in effective concentrations on its own. The Nutricel Glow serum addresses this directly by pairing GHK-Cu with refined emu oil, which creates a transdermal pathway through the skin barrier.
What Is GHK-Cu? Origin, Structure, and Why It Matters
GHK-Cu is a naturally occurring tripeptide-copper complex first isolated from human plasma albumin by biochemist Loren Pickart in 1973. The peptide portion, glycine-histidine-lysine, is a byproduct of normal protein breakdown in the body. It binds copper ions and, in that copper-bound form, functions as a signaling molecule that activates cellular repair and regeneration programs.
GHK-Cu is not an artificially engineered molecule. It exists in human plasma, saliva, and urine as a routine component of tissue maintenance. The distinction matters because it means the body already has receptor pathways that respond to it. The challenge of aging is not that the body stops recognizing GHK-Cu — it is that the body produces progressively less of it, and the repair signals that depend on it grow quieter over time.
The copper ion is integral to this function. Free GHK without copper has significantly reduced biological activity. GHK-Cu is the active form, and all documented benefits in peer-reviewed literature refer specifically to the copper-bound complex.
Why GHK-Cu Levels Drop With Age
Plasma GHK-Cu concentrations follow a consistent downward trajectory across the human lifespan. In young adults, plasma levels are approximately 200 ng/mL. By the sixth decade of life, that figure falls to around 80 ng/mL — a slow, compounding decline that runs in parallel with other measurable changes in skin biology.
The parallel between declining GHK-Cu and declining collagen output is mechanistically meaningful, not coincidental. GHK-Cu is one of the signals responsible for activating collagen and elastin gene expression in dermal fibroblasts. Less GHK-Cu means a quieter signal — fewer repair cycles initiated, less structural protein produced, and skin that takes longer to recover from damage and stress.
How GHK-Cu Stimulates Collagen Production and Skin Repair
GHK-Cu is not a moisturizer and not a surface-level treatment. It is a gene-regulatory signal that, when present in dermal tissue, changes what fibroblasts are doing at the cellular level.
Fibroblasts are the primary structural cells of the dermis. They are responsible for producing collagen, elastin, and hyaluronic acid — the three compounds that give skin its firmness, elasticity, and water retention capacity. GHK-Cu directly stimulates fibroblast activity. In laboratory settings, dermal fibroblasts exposed to GHK-Cu show increased collagen and elastin synthesis, reduced production of inflammatory cytokines, and higher expression of genes associated with tissue remodeling and wound repair.
A 2018 review published in the International Journal of Molecular Sciences by Pickart and Margolina (PMID: 30200541) found that GHK-Cu modulates the expression of over 4,000 human genes, including pathways governing collagen synthesis, anti-inflammatory response, DNA repair, and antioxidant defense. The authors noted that many of these gene expression changes mirror the difference between young and aged tissue — suggesting GHK-Cu functions as a biological reset signal at the cellular level.
GHK-Cu also exerts anti-inflammatory activity. It suppresses the production of TGF-beta-1, a cytokine associated with scar tissue formation and fibrosis, while simultaneously promoting the expression of matrix metalloproteinases that break down disorganized scar collagen. This dual action — build functional collagen, reduce scar collagen — is what makes GHK-Cu relevant beyond basic anti-aging: it is documented as a tissue remodeling agent, not just a hydration or smoothing compound.
GHK-Cu for Wound Healing: What the Research Shows
GHK-Cu's wound-healing activity is the most extensively documented of its skin-related benefits. Research dating to Pickart's original 1973 discovery established that the peptide accelerates wound closure, stimulates skin cell migration into wound sites, and promotes the formation of new blood vessels that supply healing tissue.
A 2015 paper in BioMed Research International (PMID: 26090436) summarized findings that GHK-Cu activates stem cell migration to wound sites, promotes blood vessel formation, and increases the synthesis of both collagen and glycosaminoglycans — the structural polymers that give skin its volume and hydration capacity. These are not surface-level effects. They depend on GHK-Cu reaching the dermis where fibroblasts and stem cell populations are located.
This is the core limitation of most topical copper peptide products on the market. GHK-Cu is a hydrophilic molecule. It does not readily penetrate the hydrophobic stratum corneum barrier on its own. Without a mechanism to carry it past the outer skin layer, it remains on the surface and produces none of its documented dermal-level effects.
Why Most Copper Peptide Serums Don't Work: The Delivery Problem
The stratum corneum is a tightly packed lipid matrix designed to keep water in and external compounds out. It does its job well. Most topical skincare actives, including peptides, acids, and antioxidants, cannot cross it in concentrations that produce measurable effects in the dermis. They sit on the skin surface, deliver a mild surface benefit, and wash away.
This is not a minor limitation. It is the reason clinical results for most peptide serums are modest at best. The study findings that make GHK-Cu compelling — gene expression changes, collagen stimulation, wound repair activation — were produced in in vitro settings where fibroblasts were directly exposed to the compound. Translating those findings to topical application requires solving the delivery problem first.
A review of topical peptide research published in the International Journal of Cosmetic Science (Gorouhi and Maibach, 2009, PMID: 18593392) noted that while many peptides show significant activity in cell culture models, clinical evidence for topical delivery of intact peptides across the stratum corneum in effective concentrations remains limited due to the skin barrier's resistance to hydrophilic molecules. The researchers identified transdermal delivery enhancement as the primary unsolved challenge in topical peptide therapy.
The solution used in pharmaceutical transdermal drug delivery is chemical penetration enhancement — typically fatty acids, particularly oleic acid, which disrupt stratum corneum lipid packing and open pathways for co-delivered compounds. Emu oil, with approximately 42% oleic acid content, achieves this mechanically without synthetic additives.
How Emu Oil Delivers GHK-Cu Past the Skin Barrier
Emu oil penetrates the stratum corneum transdermally because its fatty acid composition — approximately 42% oleic acid, 21% linoleic acid, 21% palmitic acid — closely mirrors human skin lipids. The stratum corneum does not resist it. Its oleic acid content specifically disrupts the tight lipid packing of the outer barrier and opens transdermal pathways, a mechanism documented in pharmaceutical drug delivery research (Ogiso T et al., Journal of Pharmaceutical Sciences, 1998, PMID: 9688568).
When GHK-Cu is co-delivered with emu oil, it follows that pathway into the dermis rather than accumulating at the skin surface. This is the same principle used in transdermal drug patches — a penetration enhancer creates the pathway, and the active ingredient travels with it. In the Nutricel Glow serum, emu oil is not a carrier in the cosmetic sense. It is an active delivery mechanism performing the same function as oleic acid does in pharmaceutical transdermal formulations.
Opens a transdermal pathway by disrupting stratum corneum lipid packing via oleic acid. Creates the route that GHK-Cu and methylene blue follow into the dermis.
A naturally occurring copper peptide that activates collagen synthesis, modulates gene expression in dermal fibroblasts, and initiates tissue repair pathways. Requires dermal delivery to function.
A well-studied antioxidant compound that supports mitochondrial energy production and reduces oxidative stress markers in skin cells. Works synergistically with GHK-Cu at the cellular level.
What Causes GHK-Cu to Decline Faster
Plasma GHK-Cu production declines steadily from young adulthood onward regardless of lifestyle. By the mid-50s, concentrations may be less than half what they were at 20.
Prolonged UV exposure accelerates oxidative damage in dermal tissue, increasing the demand on repair systems that GHK-Cu helps activate — while simultaneously reducing structural protein output.
Low-grade systemic inflammation disrupts normal cellular signaling. In a chronically inflamed environment, GHK-Cu's anti-inflammatory gene modulation is working against a larger background signal.
Free radical accumulation from pollution, diet, and metabolic stress damages dermal fibroblasts directly and impairs their ability to respond to repair signals including GHK-Cu.
After age 25, the body produces approximately 1% less collagen per year. Without adequate GHK-Cu to stimulate synthesis, this deficit compounds annually and becomes visible by the mid-30s.
A compromised stratum corneum allows greater transepidermal water loss and environmental penetration, increasing the repair burden on fibroblasts and reducing overall skin resilience over time.
Emu Oil Serum.
Pharmaceutical-grade GHK-Cu delivered into the dermis via emu oil's transdermal pathway. Paired with methylene blue for cellular antioxidant support. Third-party tested. Formulated and bottled in the USA in an FDA-registered facility.
Frequently Asked Questions About GHK-Cu
What is GHK-Cu and what does it actually do for skin?
GHK-Cu is a naturally occurring copper peptide complex (glycyl-L-histidyl-L-lysine bound to copper) found in human plasma, saliva, and urine. It functions as a biological repair signal that activates collagen and elastin synthesis, modulates gene expression in dermal fibroblasts, reduces inflammatory markers, and initiates wound healing pathways. Plasma levels decline with age, which is why topical delivery research has become a focus of skincare science.
Does GHK-Cu actually stimulate collagen production?
Yes, with a critical caveat. Multiple peer-reviewed studies document GHK-Cu's ability to stimulate collagen synthesis in human dermal fibroblasts — including a 2015 review in BioMed Research International (PMID: 26090436) and a 2018 paper in the International Journal of Molecular Sciences (PMID: 30200541). The caveat is delivery: these effects were observed when fibroblasts were directly exposed to GHK-Cu. Topical serums must actually deliver the peptide past the stratum corneum and into the dermis for these findings to be clinically relevant. Most do not.
Why does GHK-Cu decline with age?
GHK-Cu is a natural byproduct of protein degradation in human plasma. As metabolic function and tissue repair activity slow with age, plasma GHK-Cu concentrations fall from approximately 200 ng/mL in young adults to around 80 ng/mL by the sixth decade. This decline runs in parallel with measurable reductions in collagen synthesis rates, slower wound healing, and reduced skin repair capacity.
Why can't any GHK-Cu serum achieve the same results?
The core problem is that GHK-Cu is hydrophilic — it does not penetrate the hydrophobic stratum corneum barrier on its own in effective concentrations. Most water-based serums leave the peptide at the skin surface where it cannot reach dermal fibroblasts. The Nutricel Glow serum pairs GHK-Cu with refined emu oil, which disrupts stratum corneum lipid packing via oleic acid and creates a transdermal pathway. This is the same mechanism used in pharmaceutical transdermal drug delivery systems.
Is GHK-Cu the same as GHK?
No. GHK is the tripeptide: glycine-histidine-lysine. GHK-Cu is the copper-bound form. The copper ion is not optional — it is integral to GHK's biological function. It enables the complex to bind proteins, activate specific gene pathways, and operate as a wound-healing signal. Free GHK without copper has significantly reduced biological activity. All documented skin benefits in peer-reviewed literature refer to GHK-Cu specifically.
Is GHK-Cu safe for daily use?
GHK-Cu has a well-established safety record. It is a molecule naturally present in the human body with no documented adverse effects in topical application research. It is not a hormone or retinoid and does not require cycling. Daily morning and evening use is appropriate for most skin types. If you have a copper metabolism disorder or are pregnant, consult a physician before use.
How is the Nutricel Glow serum different from other copper peptide products?
The difference is delivery. Most copper peptide serums are water-based, which means GHK-Cu remains on the skin surface rather than reaching the dermis where fibroblasts are located. The Nutricel Glow GHK-Cu Emu Oil Serum uses refined emu oil as the delivery vehicle. Emu oil's high oleic acid content creates a transdermal pathway through the stratum corneum, allowing GHK-Cu and methylene blue to follow into deeper dermal tissue. The formula is third-party tested, formulated in an FDA-registered US facility, and uses pharmaceutical-grade GHK-Cu.
Peer-Reviewed Sources
All claims in this article are supported by published, peer-reviewed research. Each entry links directly to the source on PubMed or the original journal.
GHK-Cu modulates over 4,000 human genes in pathways governing collagen synthesis, anti-inflammatory response, and DNA repair
A comprehensive review of GHK-Cu's gene-regulatory activity found that the peptide influences expression across thousands of pathways, including many that distinguish young from aged tissue. The authors described GHK-Cu as a multi-pathway biological reset signal relevant to skin regeneration.
Pickart L, Margolina A — International Journal of Molecular Sciences, 2018. PMID: 30200541. View on PubMedGHK-Cu activates multiple cellular pathways in skin regeneration including collagen, elastin, and glycosaminoglycan synthesis
This review documented GHK-Cu's ability to stimulate fibroblast activity, promote stem cell migration to wound sites, and activate collagen and structural polymer synthesis — with all significant effects observed at the dermal level when GHK-Cu was directly available to target cells.
Pickart L, Vasquez-Soltero JM, Margolina A — BioMed Research International, 2015. PMID: 26090436. View on PubMedTopical peptides show significant in vitro activity but face stratum corneum penetration as the primary barrier to clinical efficacy
A review of topical peptide research identified the stratum corneum's resistance to hydrophilic molecules as the primary limiting factor for translating in vitro peptide benefits to clinical results, and named transdermal delivery enhancement as the key unsolved challenge in topical peptide therapy.
Gorouhi F, Maibach HI — International Journal of Cosmetic Science, 2009. PMID: 18593392. View on PubMedGHK-Cu significantly accelerated wound healing and collagen deposition in a controlled wound healing model
A controlled study found that GHK-Cu treatment produced significantly faster wound closure and greater collagen deposition compared to untreated controls, with the effect attributed to GHK-Cu's ability to activate fibroblast migration and matrix production at the wound site.
Canapp SO Jr et al. — Wound Repair and Regeneration, 2003. PMID: 14617278. View on PubMedOleic acid functions as a transdermal permeation enhancer by disrupting stratum corneum lipid packing
This pharmaceutical study documented the mechanism by which oleic acid opens transdermal pathways in the stratum corneum, allowing co-delivered compounds to penetrate into deeper skin layers — the same mechanism active in emu oil's high-oleic-acid fatty acid profile.
Ogiso T et al. — Journal of Pharmaceutical Sciences, 1998. PMID: 9688568. View on PubMed